Human PD-L1 inhibitor II – 1 mg

Overview

The Human PD-L1 Inhibitor II peptide is an essential tool for researchers investigating immune checkpoint mechanisms, specifically the interaction between programmed cell death 1 (PD-1) receptors and PD-L1 ligands. This peptide plays a critical role in modulating immune responses, particularly in cancer therapy. By effectively blocking the PD-1/PD-L1 binding, it aids in restoring T cell activation and enhancing the body’s immune defense against tumor cells that overexpress PD-L1.

Key Features

• Inhibits PD-1/PD-L1 interaction
• Specifically designed for human PD-1 binding
• Contains key anchor residues, WDY
• Ideal for cancer research and immunotherapy studies
• High purity and quality for reliable results

Specifications

FAQ

What is the role of Human PD-L1 Inhibitor II?

This peptide is designed to inhibit the PD-1/PD-L1 interaction, which is crucial for modulating immune responses in cancer therapy. Its ability to block this binding allows for enhanced T cell activity against tumors.

How do I use the Human PD-L1 Inhibitor II?

The Human PD-L1 Inhibitor II can be used in various laboratory settings, including binding assays and immunotherapy research. It’s important to follow the specific experimental protocols relevant to your research.

Where can I find more peptide options?

You can explore a variety of peptides compatible with your research needs in our extensive collection of peptides available at AnaSpec.

To ensure you have the right tools for your research needs, consider pairing the Human PD-L1 Inhibitor II with our other products, such as the PKG Substrate or Autocamtide-2 for comprehensive studies on protein interactions and enzyme substrate activity.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled